Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO

Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 27; p. vi308
Main Authors: Berton-Rigaud, D., Selle, F., Floquet, A., Mollon, D., Lescaut, W., Kaminsky, M.-C., Ray-Coquard, I.L., Largillier, R., Savoye, A.-M., Barletta, H., Pautier, P., Orfeuvre, H., Baron, M., Marti, A., Mouysset, J.-L., Paoli, J.-B., Cailleux, P.-E., Cornea, C., Pujade-Lauraine, E.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2016
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdw374.42